Hypertension in patients with PRES is usually secondary to treatment (steroids, cyclosporin), low serum magnesium levels or renin-angiotesin-aldosteron system response to tumour-compressing renal vasculature. This evidence concerns the gene REN and Posterior Leukoencephalopathy Syndrome.